Literature DB >> 22609952

Characterization of the biochemical properties of two methionine aminopeptidases of Cryptosporidium parvum.

Jung-Mi Kang1, Hye-Lim Ju, Woon-Mook Sohn, Byoung-Kuk Na.   

Abstract

We identified two methionine aminopeptidases of Cryptosporidium parvum (CpMetAP1 and CpMetAP2) and characterized the biochemical properties of the recombinant enzymes. CpMetAP1 and CpMetAP2 belong to the type I and type II MetAP subfamilies, respectively. Both CpMetAPs have typical amino acid residues essential for metal binding and substrate binding sites, which are conserved in the MetAP family. Bacterially expressed recombinant CpMetAP1 and CpMetAP2 showed similar biochemical properties including a broad optimal pH range (pH 7.5-8.5) with maximum activity at pH 8.0. The two enzymes were stable under neutral and alkaline pHs but were relatively unstable under acidic conditions. The activities of CpMetAP1 and CpMetAP2 increased highly in the presence of Mn(2+) and Co(2+). CpMetAP1 and CpMetAP2 were effectively inhibited by the metal chelators, EDTA and 1,10-phenanthroline, and were partially inhibited by the aminopeptidase inhibitors, amastatin and bestatin. Fumagillin also showed an inhibitory effect on both CpMetAPs.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609952     DOI: 10.1016/j.parint.2012.05.008

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  5 in total

1.  Discovery of novel antigiardiasis drug candidates.

Authors:  Liudmila Kulakova; Andrey Galkin; Catherine Z Chen; Noel Southall; Juan J Marugan; Wei Zheng; Osnat Herzberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

2.  A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies.

Authors:  Oscar Ekpenyong; Candace Cooper; Jing Ma; Dong Liang; Omonike Olaleye; Huan Xie
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-08-29       Impact factor: 3.205

3.  Recombinant methionine aminopeptidase protein of Babesia microti: immunobiochemical characterization as a vaccine candidate against human babesiosis.

Authors:  Tserendorj Munkhjargal; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Parasitol Res       Date:  2016-06-15       Impact factor: 2.289

4.  Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study.

Authors:  Maria Rincon Nigro; Jing Ma; Ololade Tosin Awosemo; Huan Xie; Omonike Arike Olaleye; Dong Liang
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

5.  Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases.

Authors:  Oscar Ekpenyong; Xiuqing Gao; Jing Ma; Candace Cooper; Linh Nguyen; Omonike A Olaleye; Dong Liang; Huan Xie
Journal:  Drug Des Devel Ther       Date:  2020-03-30       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.